Cargando…

A novel signature of two long non-coding RNAs in BRCA mutant ovarian cancer to predict prognosis and efficiency of chemotherapy

BACKGROUND: In this study we aimed to identify a prognostic signature in BRCA1/2 mutations to predict disease progression and the efficiency of chemotherapy ovarian cancer (OV), the second most common cause of death from gynecologic cancer in women worldwide. METHODS: Univariate Cox proportional-haz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Yinglian, Jia, Li Ping, Liu, Yuzhu, Han, Yiyu, Li, Qian, Zou, Qin, Zhang, Zhongpei, Huang, Jin, Deng, Qingchun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502206/ https://www.ncbi.nlm.nih.gov/pubmed/32950050 http://dx.doi.org/10.1186/s13048-020-00712-w

Ejemplares similares

Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response
por: Li, Chong, et al.
Publicado: (2023)

Involvement of non-coding RNAs in chemotherapy resistance of ovarian cancer
por: Shao, Yang, et al.
Publicado: (2018)

Alteration of tumor associated neutrophils by PIK3CA expression in endometrial carcinoma from TCGA data
por: Pan, Yinglian, et al.
Publicado: (2019)

Recent advances of non-coding RNAs in ovarian cancer prognosis and therapeutics
por: Chen, Mengyu, et al.
Publicado: (2022)

Protein-coding genes, long non-coding RNAs combined with microRNAs as a novel clinical multi-dimension transcriptome signature to predict prognosis in ovarian cancer
por: Meng, Xu, et al.
Publicado: (2017)

A prognostic signature based on cuprotosis-related long non-coding RNAs predicts the prognosis and sensitivity to chemotherapy in patients with colorectal cancer
por: Li, Wei, et al.
Publicado: (2022)

Long Non-coding RNAs Involved in Resistance to Chemotherapy in Ovarian Cancer
por: Abildgaard, Cecilie, et al.
Publicado: (2020)

Olaparib treatment for BRCA-mutant ovarian cancer with leptomeningeal disease
por: Bangham, Madeleine, et al.
Publicado: (2016)

The BRCA1/2-directed miRNA signature predicts a good prognosis in ovarian cancer patients with wild-type BRCA1/2
por: Gu, Yunyan, et al.
Publicado: (2014)

An immune infiltration-related long non-coding RNAs signature predicts prognosis for hepatocellular carcinoma
por: Li, Gen, et al.
Publicado: (2022)

A Three-mRNA Signature Associated with Pyrimidine Metabolism for Prognosis of BRCA
por: Zhang, Xiaoxue, et al.
Publicado: (2022)

Hypoxia-Activated Alkylating Agents in BRCA1-Mutant Ovarian Serous Carcinoma
por: Conroy, Michael, et al.
Publicado: (2017)

Long non-coding RNAs in ovarian cancer
por: Zhan, Lei, et al.
Publicado: (2018)

Non-Coding Variants in BRCA1 and BRCA2 Genes: Potential Impact on Breast and Ovarian Cancer Predisposition
por: Santana dos Santos, Elizabeth, et al.
Publicado: (2018)

Construction and validation of four-metabolism related-long non-coding RNAs as potential signature in prognosis of colon cancer
por: Chen, Guanxuan, et al.
Publicado: (2022)

Developing four cuproptosis-related lncRNAs signature to predict prognosis and immune activity in ovarian cancer
por: Liu, Li, et al.
Publicado: (2023)

Two protein-coding genes act as a novel clinical signature to predict prognosis in patients with ovarian serous cystadenocarcinoma
por: Zhang, Jue, et al.
Publicado: (2018)

Non-coding RNAs in the Ovarian Follicle
por: Battaglia, Rosalia, et al.
Publicado: (2017)

Novel tumor necrosis factor-related long non-coding RNAs signature for risk stratification and prognosis in glioblastoma
por: Long, Shengrong, et al.
Publicado: (2023)

Integrated analysis identifies a long non-coding RNAs-messenger RNAs signature for prediction of prognosis in hepatitis B virus-hepatocellular carcinoma patients
por: Bai, Zhenzi, et al.
Publicado: (2020)

Association of HMGB1, BRCA1 and P62 expression in ovarian cancer and chemotherapy sensitivity
por: Li, Shouyong, et al.
Publicado: (2018)

Long non-coding RNAs in ovarian granulosa cells
por: Tu, Jiajie, et al.
Publicado: (2020)

Prognosis-Predictive Signature and Nomogram Based on Autophagy-Related Long Non-coding RNAs for Hepatocellular Carcinoma
por: Jia, Yu, et al.
Publicado: (2020)

A Hypoxia-Related Long Non-Coding RNAs Signature Associated With Prognosis in Lower-Grade Glioma
por: Feng, Qinglin, et al.
Publicado: (2021)

Identification of the ferroptosis-related long non-coding RNAs signature to improve the prognosis prediction and immunotherapy response in patients with NSCLC
por: Li, Meng, et al.
Publicado: (2021)

Germline BRCA, chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancer
por: Lee, Yong Jae, et al.
Publicado: (2020)

Mitophagy-related long non-coding RNA signature predicts prognosis and drug response in Ovarian Cancer
por: Wang, Jiao, et al.
Publicado: (2023)

A novel signature based on necroptosis-related long non-coding RNAs for predicting prognosis of patients with glioma
por: Xia, Pengfei, et al.
Publicado: (2022)

A cuproptosis-related lncRNAs signature for prognosis, chemotherapy, and immune checkpoint blockade therapy of low-grade glioma
por: Yan, Xiuwei, et al.
Publicado: (2022)

To PARPI or Not to PARPI BRCA Mutated Ovarian Cancer Following First-line Chemotherapy, That is the Question?
por: Rose, Peter G, et al.
Publicado: (2021)

Identification of a novel gene signature predicting response to first-line chemotherapy in BRCA wild-type high-grade serous ovarian cancer patients
por: Buttarelli, Marianna, et al.
Publicado: (2022)

PARP Inhibitors Display Differential Efficacy in Models of BRCA Mutant High-Grade Serous Ovarian Cancer
por: Dickson, Kristie-Ann, et al.
Publicado: (2021)

Case Report: Niraparib-Related Pulmonary Embolism During the Treatment of BRCA Mutant Advanced Ovarian Cancer
por: Wei, Qiang, et al.
Publicado: (2022)

A new ferroptosis-related signature model including messenger RNAs and long non-coding RNAs predicts the prognosis of gastric cancer patients
por: Liu, Yang, et al.
Publicado: (2023)

Association of BRCA1/2 mutations with ovarian cancer prognosis: An updated meta-analysis
por: Huang, Yong-Wen
Publicado: (2018)

BRCA1/2 Mutation Types Do Not Affect Prognosis in Ovarian Cancer Patients
por: Liontos, Michalis, et al.
Publicado: (2021)

A ten N6‐methyladenosine‐related long non‐coding RNAs signature predicts prognosis of triple‐negative breast cancer
por: Wu, Jie, et al.
Publicado: (2021)

Construction and validation of a necroptosis-related lncRNAs prognosis signature of hepatocellular carcinoma
por: Peng, YunZhen, et al.
Publicado: (2022)

The role of non-coding RNAs in chemotherapy for gastrointestinal cancers
por: Dashti, Fatemeh, et al.
Publicado: (2021)

Mutations of BRCA1, BRCA2, and PALB2 Genes in Breast Tumor Tissue: Relationship with the Effectiveness of Neoadjuvant Chemotherapy and Disease Prognosis
por: Tsyganov, Matvey M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d63r8j8n30hv0796nahb3fbptp